Recently Spain’s medicines regulatory bodies announced the requirement of additional “economic evaluation” data for therapeutics positioning reports (IPTs) which is the equivalent of a Health Technology Assessment process in the country. This change is part of a revolution of the overall HTA process…
Month: December 2020
December 3, 2020
Spain will Require Pricing & Cost of Treatment Data for HTA submissions from Next Year: 2021, the Year of Data?